Expanded Access in Latin America: Real‑World Lessons from Rare Disease Programs
- Navigating regulatory and importation bottlenecks in Latin America, including the impact of government changes and evolving approval pathways (with a focus on Mexico, Argentina, and Brazil)
- Managing operational and supply‑chain challenges in rare disease Expanded Access Programs while balancing global standards with country‑specific realities
- Strengthening physician engagement to sustain program momentum and patient access in high‑complexity regions